Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
NCT01406821 is an interventional trial sponsored by Stanford University. As of 21 Nov 2026, it is completed. It studies Tendinopathy. The registry lists an enrollment of 30 participants at 2 sites in 1 country. The registry lists a start date of 31 Aug 2009 and a primary completion date of 15 Mar 2019.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT01406821 |
| Status | Completed |
| Study type | Interventional trial |
| Lead sponsor | Stanford University |
| Enrollment | 30 |
| Registered sites | 2 |
| Countries | 1 |
| Conditions | Tendinopathy |
| Start | 31 Aug 2009 |
| Primary completion | 15 Mar 2019 |
| Study completion | 15 Mar 2019 |
| Last update posted | 29 Mar 2019 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Dr. Christina Herrero
New York University Langone Orthopedic Hospital
Study Director - Dr. Jason L. Dragoo
Stanford University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stanford University School of Medicine
Stanford
- New York University Langone Orthopedic Hospital
New York
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT01406821
Each answer restates registry values shown on this page.
What is NCT01406821?
NCT01406821 is an interventional trial sponsored by Stanford University. It studies Tendinopathy.
Who leads NCT01406821?
The registry names Dr. Christina Herrero (study director, New York University Langone Orthopedic Hospital) and Dr. Jason L. Dragoo (principal investigator, Stanford University) as overall officials.
Where does NCT01406821 run?
The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.
When did NCT01406821 end?
The registry lists a primary completion date of 15 Mar 2019 and a study completion date of 15 Mar 2019. The sponsor last updated the record on 29 Mar 2019.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.